Research You Can Use: Impact of the 2020 COVID-19 Pandemic on Ambulatory Hepatitis C Testing
Premiere Date: Wednesday, March 31, 2021This activity offers CE credit for:
- Physicians (CME)
- Pharmacists (ACPE)
- ABIM (MOC)
- Other
All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™
Credit Expiration Date:
Thursday, March 31, 2022
Note: Credit Is No Longer Available
 | Mark S. Gold, MD ASAM's Annual Lifetime Achievement John P. McGovern Award & Prize Winner Adjunct Professor of Psychiatry Washington University School of Medicine St. Louis, MO 17th University of Florida Distinguished Alumni Professor Gainesville, FL |
COVID-19 has had a significant impact on testing and identification and has forced rapid restructuring in hospital-wide and ambulatory settings. Telemedicine has been incorporated into clinical workflows, with much preventive care, including hepatitis C virus (HCV) testing, not being routinely performed. Hospital-wide, total HCV testing has decreased by 49.6% and new HCV-positive patient identification has decreased by an alarming 42.1%. Ambulatory clinic testing has decreased by a staggering 71.9% and new HCV-positive patient identification has decreased by 63.3%. The COVID-19 systematic emergency response has led to decreased HCV testing and identification, with telemedicine being a barrier to HCV care.
This CME Outfitters Newsletter article features insight on the challenges, consequences, and opportunities created by COVID-19 in the testing and treatment rates of HCV globally.
At the end of this CE activity, participants should be able to:
- Apply CDC universal screening guidelines to improve diagnosis of HCV and linkage to treatment
The following learning objectives pertain only to those requesting CNE or CPE credit:
- Describe the CDC universal screening guidelines to improve diagnosis of HCV and linkage to treatment
Supported by an educational grant from Gilead Sciences, Inc
Primary care physicians, emergency medicine physicians, addiction specialists, PAs, nurse practitioners, and pharmacists
CME Credit (Physicians):
CME Outfitters, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
CME Outfitters, LLC, designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CPE Credit (Pharmacists):
CME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. .5 contact hours (0.05 CEUs) Universal Activity Number:
Enduring: 0376-0000-21-075-H01-P
Type: Knowledge-based
ABIM/MOC Credit:
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to .5 medical knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Learning Format
Enduring material
Note to Nurse Practitioners: Nurse practitioners can apply for AMA PRA Category 1 Credit TM through the American Academy of Nurse Practitioners (AANP). AANP will accept AMA PRA Category 1 Credit TM from organizations accredited by the Accreditation Council for Continuing Medical Education. Nurse practitioners can also apply for credit through their state boards.
Royal College MOC:
Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME's "CME in Support of MOC" program in Section 3 of the Royal College's MOC Program.
MIPS Improvement Activity: This activity counts towards MIPS Improvement Activity requirements under the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA). Clinicians should submit their improvement activities by attestation via the CMS Quality Payment Program website.
Note to PAs: PAs may claim a maximum of .5 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.
Post-tests, credit request forms, and activity evaluations must be completed online (requires free account activation), and participants can print their certificate or statement of credit immediately (75% pass rate required). This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit https://www.cmeoutfitters.com/privacy-and-confidentiality-policy
Disclosure Declaration
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CME/CECE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.
Dr. Gold has no disclosures to report.
Susan Perry (planning committee) has no disclosures to report.
Jan Perez (planning committee) has no disclosures to report.
Sharon Tordoff (planning committee) has no disclosures to report.
Disclosures were obtained from the CME Outfitters, LLC staff: No disclosures to report.
Faculty of this CME/CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.
Questions about this activity? Call us at 877.CME.PROS (877.263.7767).
CN-043-033121-47
